# Bicalutamide (Bicalutamide)

Source: https://ourhealthnetwork.com/drugs/bicalutamide
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Bicalutamide?

Bicalutamide is an androgen receptor inhibitor. It is prescribed to treat prostatic neoplasms. Across the United States, 5,000 doctors prescribe Bicalutamide to approximately 33,000 Medicare patients.

## Brand names

Bicalutamide

## Indications

Bicalutamide is primarily prescribed for the treatment of prostatic neoplasms.

## Conditions treated

- [Prostatic Neoplasms](https://ourhealthnetwork.com/conditions/prostatic-neoplasms)

## Mechanism of action

Bicalutamide is a non-steroidal androgen receptor inhibitor. It competitively inhibits the action of androgens by binding to cytosol androgen receptors in the target tissue.

## Drug classification

- Established Pharmacologic Class: Androgen Receptor Inhibitor [EPC]
- Mechanism of Action class: Androgen Receptor Antagonists [MoA]
- Route of administration: ORAL

## Common side effects

the most frequent adverse reaction was hot flashes (53%), Cardiovascular Hot Flashes 211 (53), 217 (53), 142 (35), 127 (31), 105 (26), 107 (26), Back Pain 102 (25)

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)